Skip to main content
PharmaTher Holdings Ltd. logo

PharmaTher Holdings Ltd. — Investor Relations & Filings

Ticker · PHRM ISIN · CA71716H1082 LEI · 529900PIPSZ1ZSWF3A21 CSE Manufacturing
Filings indexed 279 across all filing types
Latest filing 2021-03-09 Proxy Solicitation & In…
Country CA Canada
Listing CSE PHRM

About PharmaTher Holdings Ltd.

https://www.pharmather.com/

PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for a Special Meeting of shareholders scheduled for April 5, 2021. It includes instructions on appointing a proxyholder, voting methods, and voting recommendations for a proposed name change of the corporation. There are no financial statements, management discussion, or detailed report content. The document is a solicitation for votes and proxy appointment related to a shareholder meeting, not the meeting materials themselves or the voting results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 5829 characters, which is consistent with a detailed proxy form but not a full report or announcement of results.
2021-03-09 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Voting Instruction Form (VIF) for a Special Meeting of securityholders, detailing how beneficial holders can instruct voting on matters such as a proposed name change. It includes instructions on how to vote by telephone, internet, or mail, and specifies the date and time of the meeting. There are no financial statements, management discussions, or report content. This is clearly proxy-related material intended to solicit voting instructions from shareholders for a specific meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is not merely an announcement but the actual voting instruction form and related proxy materials.
2021-03-09 English
Management information circular - English.pdf
Regulatory Filings
2021-03-09 English
News release - English.pdf
Regulatory Filings
2021-03-02 English
News release - English.pdf
Regulatory Filings
2021-03-01 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a research collaboration between PharmaTher and the Terasaki Institute for developing a novel microneedle delivery system for psychedelic pharmaceuticals. It contains no financial data, no regulatory filings, no voting results, no management changes, no earnings or annual report content. It is a corporate announcement about a research collaboration and future product development plans. The document length is 6788 characters, which is relatively short and the content is clearly a news announcement rather than a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.